Cargando…
Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19
The emergence of the new corona virus (SARS-CoV-2) and the resulting COVID-19 pandemic requires fast development of novel prevention and therapeutic strategies. These rely on understanding the biology of the virus and its interaction with the host, and on agnostic phenotypic screening for compounds...
Autores principales: | Nolasco, Patricia, Borsoi, Juliana, Moraes, Carolina Borsoi, Freitas-Junior, Lucio H., Pereira, Lygia Veiga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737100/ https://www.ncbi.nlm.nih.gov/pubmed/33275129 http://dx.doi.org/10.1590/1678-4685-GMB-2020-0198 |
Ejemplares similares
-
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection
por: Franco, Caio Haddad, et al.
Publicado: (2019) -
An Image-Based Algorithm for Precise and Accurate High Throughput Assessment of Drug Activity against the Human Parasite Trypanosoma cruzi
por: Moon, Seunghyun, et al.
Publicado: (2014) -
Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes
por: Matutino Bastos, Tanira, et al.
Publicado: (2020) -
Increasing The Genetic Admixture of Available Lines of Human Pluripotent Stem Cells
por: Tofoli, Fabiano A., et al.
Publicado: (2016) -
Amazonian Plant Natural Products: Perspectives for Discovery of New Antimalarial Drug Leads
por: Pohlit, Adrian Martin, et al.
Publicado: (2013)